Article

Overcoming diagnostic difficulties in thyroid eye disease

When diplopia arises within the context of Graves? ophthalmopathy, the diagnosis is usually straightforward. However, the diagnosis becomes more complicated in the absence of previous thyroid dysfunction, when the patient has a remote history of hyperthyroidism, and when ocular symptoms present first, James Garrity, MD, explained Monday at the American Academy of Ophthalmology annual meeting.

Chicago-When diplopia arises within the context of Graves’ ophthalmopathy, the diagnosis is usually straightforward. However, the diagnosis becomes more complicated in the absence of previous thyroid dysfunction, when the patient has a remote history of hyperthyroidism, and when ocular symptoms present first, James Garrity, MD, explained Monday at the American Academy of Ophthalmology annual meeting.

“Fortunately, most patients present with ocular symptoms and hyperthyroidism at the same time; but there are outliers who present with thyroid symptoms first or who present with eye symptoms first,” said Dr. Garrity. He is from the Mayo Clinic, Rochester, MN.

He recounted the case of a patient who had 50 years between the diagnosis of thyroid dysfunction and the onset of ocular symptoms.

A study that determined the clinical features of patients with Graves’ ophthalmopathy found that 91% of all patients had lid signs during follow-up. At diagnosis, 71% had lid retraction and 43% had lid lag, pointing out the importance of lid signs in the evaluation of diplopia associated with Graves’ disease, Dr. Garrity emphasized.

There is also the small chance that these patients may have myasthenia gravis-about 5% of those with myasthenia have Graves’ disease and 0.5% of patients with Graves’ disease have myasthenia.

Exotropia in the presence of thyroid disease should send up a red flag, Dr. Garrity noted. “This is myasthenia gravis until proven otherwise,” he stated.

Lymphoma can be a masquerade diagnosis, as Dr. Garrity demonstrated in a patient diagnosed with steroid-dependent Graves’ ophthalmopathy. On evaluation, the patient had exotropia and no history of thyroid dysfunction.  Biopsy of the lateral rectus muscle showed lymphoma.

“The causes of diplopia with thyroid disease are usually straightforward. Forced ductions are usually restricted. Imaging studies, if needed, usually show enlarged extraocular muscles. However, if the morphology and the pattern are not consistent with thyroid disease, a biopsy should be performed to rule out lymphoma or metastasis. Myasthenia gravis is a consideration. Eye lid signs should be carefully sought,” Dr. Garrity advised.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.